Error: Could not add to watchlist. X

Tekla Healthcare Investors

+ Watchlist
HQH:US
New York
21.76
USD
0.72
3.42%
As of 8:04 PM EST on 2/12/2016.
Open
21.21
Day Range
21.05 - 21.78
Previous Close
21.04
52Wk Range
20.71 - 37.99
1 Yr Return
-29.13%
YTD Return
-26.64%
Open
21.21
Day Range
21.05 - 21.78
Volume
122,604
Previous Close
21.04
52Wk Range
20.71 - 37.99
1 Yr Return
-29.00%
YTD Return
-26.64%
NAV (on 02/12/2016)
24.11
Total Assets (b USD) (on 06/26/2015)
1.308
Inception Date
04/22/1987
Premium/Discount
-9.75%
Average 52-Week Premium
-0.07%
Fund Managers
DANIEL R OMSTEAD "DAN"
Last Dividend (on 12/28/2015)
0.94
Dividend Indicated Gross Yield
10.85%
Expense Ratio
1.00%
3 Mo Return
-25.89%
3 Yr Return
13.18%
5 Yr Return
18.28%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 997.39 k 97.93 m 8.87
Celgene Corp 842.97 k 91.18 m 8.26
Incyte Corp 508.32 k 56.08 m 5.08
Biogen Inc 187.39 k 54.68 m 4.95
Alexion Pharmaceuticals Inc 348.92 k 54.57 m 4.94
Regeneron Pharmaceuticals Inc 109.64 k 51.00 m 4.62
Vertex Pharmaceuticals Inc 474.88 k 49.45 m 4.48
Allergan plc 171.20 k 46.53 m 4.21
BioMarin Pharmaceutical Inc 406.55 k 42.82 m 3.88
Mylan NV 916.39 k 36.89 m 3.34
Profile
Tekla Healthcare Investors Fund is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.
ADDRESS
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
PHONE
1-617-772-8500